Back
Cancer
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors * Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy * Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration Anticancer mechanisms of cannabinoids * Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma Antitumorigenic Effects of Cannabinoids beyond Apoptosis * Association between cannabis use and the risk of bladder cancer: results from the California Men’s Health Study Cannabidiol (CBD) Priming Enhances Cisplatin Killing Of Cancer Cells Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells Cannabidiol as potential anticancer drug Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy Cannabidiol inhibits angiogenesis by multiple mechanisms * Cannabidiol Inhibits Cancer Cell Invasion Via Upregulation Of Tissue Inhibitor Of Matrix Metalloproteinases-1 Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma–Associated Herpesvirus Infected Endothelium * Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1 Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy * Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness Cannabinoid-associated cell death mechanisms in tumor models (Review) Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells Cannabinoid receptor ligands as potential anticancer agents – high hopes for new therapies Cannabinoid Receptor-Mediated Apoptosis Induced by R()-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma * Cannabinoid receptors as novel targets for the treatment of melanoma Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis * Cannabinoids: A new hope for breast cancer therapy? * Cannabinoids and cancer * Cannabinoids and cancer: potential for colorectal cancer therapy Cannabinoids and cancer: pros and cons of an antitumour strategy * Cannabinoids and ceramide: two lipids acting hand-by-hand * Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators Cannabinoids as therapeutic agents in cancer: current status and future implications Cannabinoids, Endocannabinoids and Cancer Cannabinoids for Cancer Treatment: Progress and Promise Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas * Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients Cannabinoids: potential antitumoral agents? Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition * Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells Cannabis and Cannabinoids (PDQ®) – National Cancer Institute | Patient Cannabis and Cannabinoids (PDQ®) – National Cancer Institute | Healthcare Professional Cannabis in cancer care Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation CBD inhibits angiogenesis by multiple mechanisms * Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group COX-2 and PPAR-g Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells Delta-9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo * Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized-double-blind, placebo-controlled pilot trial * Differential role of cannabinoids in the pathogenesis of skin cancer Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study * Endocannabinoids and Cancer * Endocannabinoids and fatty acid amides in cancer inflammation and related disorders Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review) Endocannabinoids as Guardians of Metastasis Endocannabinoids in endocrine and related tumours Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1 Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors * Inhibition of tumor angiogenesis by cannabinoids Integrating cannabis into clinical cancer care Involvement of PPARc in the antitumoral action of cannabinoids on hepatocellular carcinoma Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study Medical marijuana for cancer Medical Marijuana Use in Oncology Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent Modulation of LPS-Induced Activation of BV-2 Microglial Cells Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies) Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 * Preparation and characterisation of biodegradable microparticles filled with THC and their antitumor efficacy on cancer cell lines Proapoptotic effect of endocannabinoids in prostate cancer cells Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth Regulation of nausea and vomiting by cannabinoids * Structure-dependent inhibitory effects of synthetic cannabinoids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and skin tumour promotion in mice Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids The cannabinoids: An overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection * The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 The endocannabinoid system and cancer: therapeutic implication The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care The potential relevance of the endocannabinoid, 2- arachidonoylglycerol, in diffuse large B-cell lymphoma The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications The role of cannabinoids in the treatment of children with cancer The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells The use of cannabinoids as anticancer agents * Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis * Towards the use of cannabinoids as antitumour agents United States patent application publication for phytocannabinoids in the treatment of cancer
